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Background: Chronic diseases are major causes of disability worldwide with rising prevalence. Most patients
suffering from chronic conditions do not always receive optimal care. The Chronic Care Model (CCM) has been
developed to help general practitioners making quality improvements. The Patient Assessment of Chronic Illness
Care (PACIC) questionnaire was increasingly used in several countries to appraise the implementation of the CCM
from the patients’ perspective. The objective of this study was to adapt the PACIC questionnaire in the French
context and to test the validity of this adaptation in a sample of patients with multiple chronic conditions.
Methods: The PACIC was translated into French language using a forward/backward procedure. The French version
was validated using a sample of 150 patients treated for obstructive sleep apnea syndrome (OSAS) and having
multiple chronic co-morbidities. Several forms of validity were analysed: content; face; construct; and internal
consistency. The construct validity was investigated with an exploratory factorial analysis.
Results: The French-version of the PACIC consisted in 18 items, after merging two pairs of items due to
redundancy. The high number of items exhibiting floor/ceiling effects and the non-normality of the ratings
suggested that a 5-points rating scale was somewhat inappropriate to assess the patients’ experience of care. The
construct validity of the French-PACIC was verified and resulted in a bi-dimensional structure. Overall this structure
showed a high level of internal consistency. The PACIC score appeared to be significantly related to the age and
self-reported health of the patients.
Conclusions: A French-version of the PACIC questionnaire is now available to evaluate the patients’ experience of
care and to monitor the quality improvements realised by the medical structures. This study also pointed out some
methodological issues about the PACIC questionnaire, related to the format of the rating scale and to the structure
of the questionnaire.Background
Chronic diseases are major causes of disability worldwide
and prevalence is rising [1]. In France, the number of
patients officially identified as having at least one chronic
condition rose from 3.7 million in 1994 up to 9 million in
2008, and could reach 12 million in 2015 [2]. In addition
to the medical burden, the growth of chronic conditions
places a high financial burden on the healthcare systems.
In 2007, the amount of public insurance reimbursements
to those patients was estimated at 80 billion euros [3].* Correspondence: nicolas.krucien@abdn.ac.uk
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reproduction in any medium, provided the orDespite these large expenditures, patients suffering
from chronic conditions do not always receive optimal
care [4,5]. There is evidence that a long-term, structured,
and proactive approach can help to reduce the burden
of chronic diseases, but the organization of medical care
is still mainly oriented toward acute conditions [6]. The
management of chronic conditions is often more com-
plex than that of acute conditions, because i) it involves
several actors practicing in different sites, ii) the patient
plays a key role in the treatment effectiveness through
his/her health habits and regular compliance, and iii)
given the long-term nature of the chronic conditions,
chronic care has to deal with symptoms and to antici-
pate further complications. Then acute care organizationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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patients with chronic conditions and to achieve effective
and high quality healthcare system [7,8].
In practice, the management of chronic conditions is
mainly based on primary care and especially on services
dispensed by the general practitioner (GP) [9]. In most
countries, including France, the GP usually acts as a
gatekeeper and he/she is the first health professional to
adapt to the growing burden of chronic conditions [10].
The chronic care model (CCM) has been developed to
help GPs make the transition from acute care to chronic
care [11] and it is widely adopted in several countries as
a framework to reform the organization of GP care. The
CCM describes a set of 6 elements designed to optimize
the management of chronic illness, namely community
linkages, organizational support, self-management sup-
port, delivery system design, decision support, and clin-
ical information systems. The goal of treatment aligned
with CCM principles is to create an informed, activated
patient interacting with a prepared, proactive practice
team, resulting in productive encounters and improved
outcomes [12]. There is evidence that interventions
containing at least one CCM element could lead to im-
proved patient care and health outcomes [13-15]. For
example, patients suffering from chronic obstructive
pulmonary disease and benefiting from a care including
CCM components showed lower rates of hospitalizations,
and shorter hospital stays [16].
In line with the increasing use of the CCM to improve
the quality of the chronic care and the recent trend to
make healthcare systems more accountable for the pa-
tients’ needs, Glasgow et al. have developed the “Patient
Assessment of Chronic Illness Care” (PACIC) question-
naire to appraise the implementation of the CCM from
the patients’ perspective [17]. To date the PACIC ques-
tionnaire has been used in several countries to evaluate
the delivery of CCM activities for a variety of chronic
conditions (Table 1), but there is no version available in
French language. In addition, validation studies have
shown mixed evidence regarding the data quality and
the properties of the PACIC scales [18,19].
The objective of this study was to translate the PACIC
questionnaire into the French language and to test the
validity of this adaptation in a sample of patients suffer-
ing from obstructive sleep apnea syndrome (OSAS) and
other frequent chronic conditions. We were especially
interested in the validation of the PACIC survey in a
sample of patients suffering from multiple chronic con-
ditions, because in practice GPs face a growing number
of these patients and most of the time these patients re-
quire more complex medical care.
The remainder of this study is divided into four sec-
tions. Section 1 presents the methods used to translate and
validate the PACIC questionnaire in the French language.Section 2 presents the results of the French-PACIC ques-
tionnaire and the level of achievement of the CCM recom-
mendations in the French context. Section 3 discusses the
results of this study. Finally, section 4 provides concluding
remarks on this adaptation and validation of the PACIC
questionnaire in French context.
Methods
Sample of patients with multiple chronic conditions
Definition of the sample size
The sample size was defined according to Hatcher (1994)
who recommended that the number of subjects should
be 5 times the number of variables (equivalently a 5:1
subject-to-variable (STV) ratio), with a minimum of
100 subjects [20]. In a recent 2-years literature review
of the published factorial analyses (exploratory factor
and principal components analyses), Costello & Osborne
[21] showed that 40.5% of the studies used a sample size
with a STV ratio lower than 5:1 and 36.8% of the studies
with a ratio larger than 10:1. In a simulation study,
MacCallum et al. (1999) showed a perfect recovery of
population factor structure with a 3:1 ratio (i.e. 60 sub-
jects and 20 variables) [22]. In this study, we expected
a maximum number of 20 items. Then a minimal sample
size of 100 respondents was required. Finally we decided
to recruit 150 individuals to obtain a large enough sample
after accounting for missing values.
Identification of the patients suffering from multiple
chronic conditions
The OSAS chronic condition was used as a way to identify
patients suffering from multiple chronic conditions already
analysed in the international literature (e.g. Diabetes).
As shown in this study, on average the recruited pa-
tients suffered from 2.2 chronic conditions in addition
to their OSAS. In addition, at least in the French con-
text, the GP is usually not involved in the management
and treatment of the OSAS, which is largely treated by
hospital-based pulmonary specialist. Then the OSAS
condition was assumed to be of minor influence (if any)
on the patients’ perception of the quality of the chronic
care delivered by their GP.
To rule out a potential influence of the OSAS condi-
tion on the results and to be included in the validation
study, patients had to meet three eligibility criteria. First,
they had to suffer from at least 1 chronic condition in
addition to their OSAS to be considered as patients with
multiple chronic conditions. Second, they had to have
experienced at least 1 GP visit in the last 6 months. This
criterion was used to ensure that respondents had a
minimal experience of the GP care. Third, they had to
comply with their OSAS treatment for at least 1 year.
Under these conditions the OSAS become asymptomatic
and the treatment is well accepted by the patients. This







Gender Age PACIC mean
score (SD)(% male) (mean + SD or %)
Maindal et al. [37] Denmark 481 DM Confirmatory 60% 66,4 (10,7) 2,83 (−)
Rosemann et al. [25] Germany 236 OA Exploratory 45% - 2,44 (1,1)
Schmittdiel et al. [46] USA 4,108 RESP; DM; HF;
CAD; Pain
No 50% 61,9 (14,7) 2,7 (1,1)
Vrijhoef et al. [44] Netherlands 89 COPD; HF; Arthritis;
Geriatric disorders
No 49% 56% “ > 65 years” 2,6 (−)
Taggart et al. [42] Australia 2,438 DM; IHD Exploratory 47% 63,2 (−) 3,01 (1,07)
Taggart et al. [42] Australia 914 DM; IHD Exploratory 43% 57,4% “ ≥ 60 years” 3,07 (1,06)
Aragones et al. [27] USA (Spanish language) 100 DM Confirmatory 21% - 3,17 (0,82)
Wensing et al. [41] Netherlands 165 DM; COPD Exploratory 53% 68 (10,3) 2,9 (1)
Rick et al. [39] UK 2,439 Various Confirmatory 51% 51,7% “ ≥ 65 years” 2,4 (0,87)
Ludt et al. [47] Europe 1,745 CVD No 68% 67,8 (9,9) 2,84 (−)
Szecsenyi et al. [45] Germany 1,399 DM No 46% 70,3 (8,5) 2,86 to 3,21
Glasgow
Glasgow et al. [24] USA 266 Various Confirmatory 44% 64,2 (10,5) 2,6 (1)
Mackey et al. [26] USA 1,823 DM No 35% 51,5 (16,7) 3,05 (1,19)
Glasgow et al. [17] USA 363 DM No 53% 64,1 (11,9) 3,2 (0,9)
Cramm & Nieboer [38] Netherlands 1,321 CVD Confirmatory 53% 63,8 (10,2) 2,68 (0,86)
Cramm & Nieboer [38] Netherlands 917 COPD No 52% 63,99 (10,19) 2,89 (0,89)
Cramm & Nieboer [48] Netherlands 1,570 CVD No 53% 66,11 (10,57) 2,77 (0,86)
Cramm & Nieboer [50] Netherlands 892 COPD No 54% 66.1 (10.6) 2.89 (0.9)
Cramm & Nieboer [49] Netherlands 283 Older people
(>65 years)
Confirmatory 46% 75.8 (6.8) -
Cramm & Nieboer [51] Netherlands 548 COPD No 54% 69.1 (10.2) 2.85 (0.92)
Gugiu et al. [19,28] USA 529 DM Confirmatory/
Exploratory
52.70% 63,4 (−) -
Spicer et al. [18] New Zealand 307 DM; CDV;
RESP; Pain
- 56% 68,4 (−) -
McIntosh [40] Canada 936 - Confirmatory - _ -
*DM: Diabetes; CVD: Cardiovascular disease; OA: Osteoarthritis; CAD: Coronary artery disease; COPD: Chronic obstructive pulmonary disease; IHD: Ischaemic heart
disease; HF: Heart failure; RESP: Respiratory problems (e.g. Asthma).
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of patients in terms of OSAS treatment.
Recruitment of the patients and administration of the survey
The respondents were consecutively recruited between
October 2010 and June 2011 in a hospital setting to
avoid biases related to recruitment in GP office when
the purpose of the study was to ask patients about their
GP care (e.g. responses heavily based on the last consult-
ation experienced, respondents’ inhibition) [23]. The pa-
tients were explicitly told that the survey was about the
medical services delivered by their GP to manage their
chronic conditions. This perspective was facilitated because
the patients were first asked about their GP consultations
and their chronic conditions to ensure their eligibility.
Then when they answered the PACIC questions they were
explicitly told to refer to the above mentioned chronicconditions and GP consultations. The data collection was
done using a self-completed survey that was administered
by a trained nurse during a follow-up visit for OSAS. In
addition to the PACIC items, the survey included questions
about respondents’ individual characteristics. The patients
completed the survey in the waiting room. The content
and design of this study were checked by a local ethic com-
mittee (Comité de Protection des Personnes Ile-de-France
VI, Pitié Salpétrière, France), which provided agreement for
the conduct of the study. Written informed consent was
obtained from the patients for the publication of this report
and any accompanying images.
Initial version of the PACIC questionnaire
The initial version of the PACIC questionnaire was de-
veloped by Glasgow et al. in the United-States with 283
patients suffering from various chronic illnesses [17].
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specified dimensions of the GP care as recommended by
the CCM (i.e. patient activation; delivery system/practice
design; goal setting/tailoring; problem solving/contextual;
follow-up/coordination). The 5 PACIC subscales did not
match perfectly with the 6 elements of the CCM because
some aspects of the model, such as clinical information
systems and organizational support, are generally not
visible to patients. These 20 items were chosen from 46
items designed by national experts on chronic illness care
and the CCM.
The achievement level of each of these items was rated
by patients on a 5-point rating scale with the following
anchors: Almost never (1), Generally not (2), Sometimes
(3), Most of the time (4), Almost always (5). However, in
the literature, studies have imposed marginal changes on
the format of the initial rating scale. Glasgow et al. [24]
and Rosemann et al. [25] stated that “Each item was
scored on a 5-point scale ranging from 1 (no or never) to
5 (yes or always)”. Mackey et al. [26] used a 5-points
scale ranging from “None of the time” through “Always”.
Aragones et al. [27] used a 5-points scale with the follow-
ing anchors, which are also those of the current official
version of the PACIC survey in English language: None of
the Time, A Little of the Time, Some of the Time, Most of
the Time and Always. Other studies have imposed changes
on the rating scale. Gugiu et al. [19,28] employed an 11-
point percentage scale ranging from 0% to 100% by units
of 10% with two end points labelled “Never” and “Always”.
In this study, the 5-points rating scale was based on the
following anchors: Never (1), Rarely (2), Sometimes (3),
Most of the time (4) and Always (5).
Translation and adaptation of the questionnaire
Translation
According to recommendations from the international
literature [29], the translation of the PACIC items into
the French language was performed following a forward/
backward multi-steps procedure. First, each author trans-
lated the list of items into the French language without
discussing this with the other authors. Second, the lists of
translated items were compared and disagreements were
discussed, if necessary a 4th expert was solicited to reach a
consensus. Third, the agreed list of translated items was
presented to an external team of health professionals
and medical researchers, mainly to assess the contextual
relevancy of the items and the understandability of their
translation. Fourth, external researchers were solicited
to perform a backward translation (from French to English
language) of the items. This multi-steps process appears
to be in line with the World Health Organization (WHO)
recommendations to translate and adapt an English
instrument in different languages [WHO, 2008]. This
approach putted emphasis on conceptual rather thanliteral (i.e. word-to-word) translations. For this purpose,
experts involved in the translation process were required
to have good knowledge of the French and English lan-
guages, to be familiar with the field of research and to
be able to translate the concepts avoiding the use of
any technical jargon.
Adaptation
The French version of the PACIC questionnaire was
piloted with 10 patients suffering from chronic illnesses by
using individual interviews. The patients were interviewed
and were asked to explain their responses (i.e. think aloud
approach). This pilot study was performed to ensure the
adequacy of the questionnaire content to the French
context. At this stage, patients had opportunities to suggest
new items, to modify the translated items, and to suggest
deletion of some of them.
Validation of the questionnaire
The validity of the French PACIC questionnaire was tested
following three steps: face validity; construct validity; and
internal consistency.
Face validity
The notion of face validity refers to the extent to which
a test is subjectively viewed as covering the concept it is
supposed to measure [30]. In practice, the face validity
of the PACIC is usually assumed to be verified because
the PACIC questionnaire is directly derived from the
CCM components. In this study, this assumption was
tested by asking a pilot sample of patients with chronic
illnesses about the relevancy of the PACIC items to de-
scribe their GP care experience.
In addition, the face validity was investigated through
analysis of the data quality using descriptive statistics and
correlation measures. The descriptive statistic included
mean, standard deviation (SD), percentage of missing values,
extent of ceiling and floor effects, and normality measures
(i.e. Kurtosis, Skewness, and Anderson-Darling statistics).
The floor and ceiling effects referred to the percentage
of respondents using the most extreme (upper or lower)
response categories. In practice, a percentage larger than
20% was associated with floor/ceiling effects [20].
Construct validity
The construct validity was tested using exploratory factor
analysis (EFA). Given the ordinal and non-normal nature
of the data collected using a 5-points rating scale, conven-
tional methods of EFA which rely on the Pearson correla-
tions and/or maximum likelihood techniques were deemed
inappropriate. Actually, Pearson correlation coefficients are
likely to underestimate the true correlations between the
PACIC items and maximum likelihood approach is based
on the unwarranted assumption of data normality. In this
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the Mplus software allowing both to handle ordered cat-
egorical variables and to use appropriate factoring method
(i.e. robust weighted least squares [WLSMV]) [31].
The Kaiser’s measure of sampling adequacy (K-MSA)
was used to evaluate suitability of data for factor analysis
[32]. A value between 0.5 and 1 suggested that the sam-
ple was appropriated for a factor analysis. Second, the
factors were selected following a parallel analysis imple-
mented in SAS using a modified version of the Kabacoff ’s
code [33]. This approach is based on the idea that non-
trivial factors should have eigenvalues greater than
those derived from randomly generated data with the
same number of variables and sample size. In this
study, 1,000 datasets were simulated. Each dataset had the
same dimension than the actual dataset (i.e. 18 variables/
columns and 148 respondents/rows). For each simulated
dataset, the variables were assumed to be normally distrib-
uted with a mean = 0 and variance = 1. Each time, the
complete factorial solution is computed (i.e. the number
of retained eigenvalues is equal to the maximum number
of variables in the analysis). Then we obtained 1,000 sets
of 18 eigenvalues computed on simulated datasets. Finally,
the 95th percentile of simulated eigenvalues was computed
and used as a lower bound to identify the number of actual
eigenvalues to select. Only the actual eigenvalues higher
than the 95th percentile of the simulated eigenvalues were
considered for the final analysis. Despite being considered
as the reference approach to identify the number of factors
to retain, the applicability of the parallel analysis is some-
what limited when the data are non-normally distributed.
In this study, the results from the parallel analysis assuming
normally distributed data were taken as an acceptable ap-
proximation of those that would be obtained with a parallel
analysis relaxing the Normality assumption.
A Geomin rotation procedure was used to simplify the
interpretation of the factors. The Geomin rotation is
an oblique rotation method allowing the factors to be
correlated. The Geomin procedure produces two types
of matrix: the ‘rotated loadings matrix’ which includes
linear combination of variables that make up the fac-
tor, and the ‘factor structure matrix’ which includes
the correlation coefficients between the variables and
the factors, thus indicating which items measure the
factors best. In this study, given the limited number of
factors (i.e. 2), the factors were interpreted according
to the factor structure matrix only.
The quality of the factorial solution was evaluated with
the root mean squared error of approximation (RMSEA)
was used. It measures the average amount of misfit be-
tween the model and the data. This measure is obtained
by investigating the factorial solution in a confirmatory
factor analysis which analyses the likelihood of observed
data given the assumed model/structure. In practice, it isusually admitted that a value of the RMSEA lower than
0.05 indicates a ‘good’ fit, [0.05-0.08] a ‘reasonable’ fit,
[0.08-0.1] a ‘mediocre’ fit and larger than 0.1 a ‘poor’ fit [34].
Reliability
The internal consistency of the French version of the
PACIC was assessed using both Cronbach alpha and
ordinal alpha coefficients. Theoretically, the Cronbach
alpha is only appropriate when variables are continuous,
and it has been shown that Cronbach-α is negatively
biased when it is used to measure the reliability of ordinal
variables [21]. However this measure is frequently used in
practice and leads to valid results despite data that are
highly skewed. According to the literature a value > 0.7
might be considered as acceptable [24].
More recently, the ordinal alpha coefficient has been
suggested as a better measure when the assumption of
normality is violated [35]. In their study based on sim-
ulated data, Zumbo et al. [35] concluded that “ordinal
alpha provides consistently suitable estimates of the
theoretical reliability, regardless of the magnitude of
the theoretical reliability, the number of scale points,
and the skewness of the scale point distributions. In
contrast, Cronbach alpha is in general a negatively biased
estimate of reliability for ordinal data”.
Implementation of the CCM in the French context
Once the French-version was validated, the responses
were used to analyze the implementation of the CCM
recommendations in GP care as perceived by the patients.
Currently, there is no indication of the best way to treat
missing values to compute PACIC score(s). We used a
conservative approach excluding from the analysis the
respondents who did not fulfill at least 75% of the items.
According to Glasgow et al., it was more reliable to focus
on the overall PACIC score (i.e. over all the items) rather
than on the scores by dimension [17]. Consequently, we
constructed a composite score using a confirmatory factor
analysis on the 18 items responses, and performed an
analysis of variance (ANOVA) of this overall PACIC
score using the following patients’ characteristics as
covariates: gender, age, self-reported health, number of
chronic conditions, and number of GP consultations
per year. The data management and statistical analyses
were performed using SAS 9.2 and MPlus software.
Results
Sample of patients with multiple chronic conditions
On average the 150 recruited patients had 2.23 chronic
conditions (SD:1.04) in addition to their OSAS. The 3 most
frequent chronic conditions were hypertension (27.7%),
diabetes (17.5%), and cardiovascular diseases (12.5%).
Regarding their medical care experience, on average the
patients had consulted a GP 4.15 times during the last
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times (SD:2.36) for a total of 7.26 medical consultations
per year (SD:3.37; Median = 6). Other individual charac-
teristics are summarized in Table 2.
Translation and adaptation of the questionnaire
Translation
The forward/backward translation procedure was success-
fully applied. The comparison of the backward translated
version to the official PACIC survey in English language
showed two systematic differences. Instead of using an
indefinite pronoun (e.g. “one told me”) and the past tense
(e.g. “I was informed”) to formulate the questions/items,Table 2 Characteristics of the respondents (N = 150)
Characteristic %








< 60 years 29.5
[60–65] years 32.2
[66–70] years 18.1








< 1 year 5.4
[1-5] years 16.6
> 5 years 78
Last GP consultation
< 15 days 20.1
[15-30] days 24.1
[1-3] months 37.5
> 3 months 18.3
Medical structure of the GP
GP working alone in the structure 52.7
GP working with other GPs in the same structure 40.7
GP working with other GPs and health professionnals in the
same structure
5.3the translated version was based on a GP-oriented
approach (e.g. “the GP told me”) and present tense
(e.g. “I am informed”). These changes arose because
during the process of translation and piloting the in-
definite pronoun approach was deemed too vague to
assess the quality of the care delivered by the medical
team. In addition, the translated version focused on
the GP role because in the French context this health
professional is the main provider of primary care and
most of the patients have never experienced something
else. The comparison of the forward translation in French
language with another untested French version of the
PACIC survey revealed no major discrepancy between
the items [36]. These analyses provide support for the
validity of our multi-step translation process.
Adaptation
The pilot study led to two major changes in the translated
version of the PACIC. First, the set of 20 items was re-
duced to one of 18 items because 2 items were perceived
as redundant by the patients. The items “Given me a
written list of things I should do to improve my health”
and “Help me to set specific goals to improve my eating
or exercise” were merged into one item “Help me to list
things to do to improve my health”. In the same way,
the items “Contact me after a visit to see how things
were going” and “Ask me how my visits with other doc-
tors were going” were also merged into only one item
“Contact me to know how things were going”. Actually
the respondents were able to detect the differences between
these closely related items, but according to their medical
experience, they explained that in practice they had no
way to distinguish one item from each other. Alternatively,
these apparently redundant items would have been kept in
the PACIC survey, but they would have been perfectly
correlated and this would imply methodological difficul-
ties in the factorial analysis.
The respondents had the opportunity to suggest new
items and this did not led to identification of new items,
thus suggesting that the initial pool of 20 items was
comprehensive enough to describe the patients’ experi-
ence of GP care.
Validation of the questionnaire
Face validity
The French-PACIC items seemed relevant to describe
respondents’ GP care experience. Respondents did not face
any difficulties completing the questionnaire.
Regarding the extent of missing values, only 4 respon-
dents out of 150 fulfilled less than 75% of the items and
were then excluded from the analysis. It remained 146
respondents who provided 2,324 observations out of
2,336 possible, a missing value rate of 0.5%. This very
high rate of completion might be partly attributable to
Table 4 Measure of the sample adequacy (MSA) for
factor analysis
Item Kaiser MSA Group
1 0.84 Very good
2 0.85 Very good
3 0.84 Very good
4 0.85 Very good
5 0.73 Good
6 0.85 Very good
7 0.85 Very good
8 0.82 Very good
9 0.83 Very good
10 0.84 Very good
11 0.78 Good





17 0.82 Very good
18 0.78 Good
Overall 0.82 Very good
Kaiser MSA: ≥ 0.9: Excellent; [0.8-0.9]: Very good; [0.7-0.8]: Good; [0.6-0.7]: Bad;
[0.5-0.6]: Very bad; < 0.5: Inacceptable.
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in which the survey took place. This 75% cut-off value was
initially selected according to minimal requirements for
the factorial analysis. Without running a formal sensitivity
analysis, our results are expected to be robust to changes
in this cut-off value because 91.3% of the respondents
completely filled the survey (i.e. 0 missing value) and 96%
completed it with less than 10% of missing values. Then,
given the sample size of this study, including/excluding
the respondents with a rate of missing values larger than
10% is not expected to change the results.
Looking at the % of ‘Never’ and ‘Always’ ratings
(Table 3), 13 items exhibited potential floor effect (i.e. %
“Never” > 20%), with 8 items having more than 50% of
their observations concentrated on this modality. Only 4
items are susceptible to ceiling effect with more than 20%
of their observations pertaining to the “Always” modality.
None of the items suffer from both floor and ceiling
effects. These results suggested non-normal distributions
and this was confirmed by the Kurtosis and Skewness
measures that depicted in most of cases positively skewed
(i.e. S > 0) and leptokurtic (i.e. K < 0) distributions.
Construct validity
First, looking at the K-MSA values (Table 4) only 2 items
showed a bad level of adequacy for a factor analysis,
namely “The GP encourages me to go to a specificTable 3 Descriptive analysis of the responses to the PACIC questionnaire
Item % missing
values
% never % always Median Kurtosis Skweness
1. The GP asks about my ideas when we made a treatment plan 2.0% 39.5% 14.3% 3 −1.49 0.22
2. The GP helps me to make a treatment plan that I could do in my daily life 4.0% 34.7% 13.6% 3 −1.44 0.19
3. The GP gives me a copy of my treatment plan 2.0% 83.7% 2.7% 1 6.54 2.73
4. The GP gives me choices about treatment to think about 2.7% 52.4% 8.2% 1 −0.29 1.00
5. The GP thinks about my values and traditions when s/he recommends
treatments to me
4.0% 73.5% 5.4% 1 1.94 1.81
6. The GP helps to plan ahead so I could take care of my illness even in hard times 2.0% 27.2% 11.6% 3 −1.27 0.14
7. The GP told me how my visits with other types of doctors help my treatment 3.3% 14.3% 51.7% 5 −0.54 −1.00
8. The GP shows me how what I do to take care of my illness influence my condition 3.3% 12.2% 42.9% 4 −0.54 −0.87
9. The GP asks me to talk about my goals in caring for my illness 3.3% 50.3% 6.1% 1 −0.05 1.07
10. The GP asks me questions about my health habits 2.7% 19.0% 18.4% 3 −1.06 −0.32
11. The GP helps me to list things that I can do to improve my health 2.0% 59.2% 8.2% 1 −0.35 1.05
12. The GP refers me to a dietician, health educator, or counsellor 2.7% 57.8% 4.1% 1 0.88 1.35
13. The GP encourages me to go to a specific group to help me with
my chronic illnesses
2.0% 86.4% 0.7% 1 9.00 3.00
14. The GP encourages me to attend programs in the community that could help me 2.7% 92.5% 0.0% 1 14.60 3.88
15. The GP asks me how my chronic illnesses affect my life 2.0% 32.7% 12.2% 2 −0.89 0.60
16. The GP asks me to talk about any problems with my medicines or their effects 3.3% 15.6% 36.1% 4 −1.12 −0.49
17. The GP asks me if I am satisfied with the organisation of my care 2.0% 44.9% 14.3% 2 −1.33 0.46
18. The GP contacts me to know how things are going 2.0% 16.3% 33.3% 4 −0.99 −0.64
GP: General practitioner.
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GP encourages me to attend programs in the commu-
nity that could help me”. The overall measure is about
0.82 and thus suggested that the observations were
suitable for the factor analysis.
Second, the parallel analysis led to the identification
of a factorial solution in 2 factors (Figure 1). It should
be noted that these 2-factors solutions also satisfied
the standard Kaiser criterion for the factors identifica-
tion (i.e. eigenvalues > 1).
Third, the Geomin rotation procedure led to a substantial
inter-factors correlation of 0.415, thus suggesting that the
two dimensions of the PACIC cannot be seen as inde-
pendent dimension. Looking at the factor structure matrix
(Table 5), each item was assigned to only one factor with
the highest contribution (i.e. magnitude of the coefficients).
According to this approach, the 1st factor would be best de-
scribed by 10 items and the 2nd factor by 8 items. However,
given the somewhat high level of inter-correlation between
the two factors, some items {3;4;9;10;11;15} seemed to
be well accounted for by both factors. The first factor
referred mainly to items describing efforts made by theFigure 1 Results of the parallel analysis to identify the number of facGP to customise the chronic care according to the pa-
tients’ needs and values (e.g. asking about ideas when
making the treatment plan; making a treatment plan
suitable in patients’ daily life; taking into account pa-
tients’ values when recommending a treatment; taking
into account the patients’ health habits; making a treat-
ment plan allowing for changes in patients situation)
and to items describing the interest of the GP in the
medical experience of the patients (e.g. asking how the
chronic conditions affect the patients’ life; asking for
problems with the medicines; asking if patients are sat-
isfied of the chronic care; contacting patients to know
if things are doing well). The second factor referred to the
actions taken by the GP to implement a collaborative
chronic care with the patients (e.g. giving a copy of the
treatment plan; giving choice about treatment; providing a
list of things to do) and other professionals (e.g. referring
to a dietician; encouraging to go to support group; encour-
aging to use community/social programs).
The resulting RMSEA value for this factorial solution
was 0.083 with a 90% CI=[0.068;0.099], thus suggesting a
‘reasonable’ level of fit.tors.
Table 5 Results of the factor analysis
Item Factor 1 Factor 2 Dimension
Factor 1
2. The GP helps me to make a treatment plan that I could do in my daily life 0.707 0.416 Customisation
5. The GP thinks about my values and traditions when s/he recommends treatments to me 0.498 0.373 Customisation
6. The GP helps to plan ahead so I could take care of my illness even in hard times 0.730 0.301 Customisation
7. The GP told me how my visits with other types of doctors help my treatment 0.544 0.048 Experience
8. The GP shows me how what I do to take care of my illness influence my condition 0.717 0.208 Cooperation
10. The GP asks me questions about my health habits 0.649 0.505 Customisation
15. The GP asks me how my chronic illnesses affect my life 0.710 0.502 Experience
16. The GP asks me to talk about any problems with my medicines or their effects 0.589 0.281 Experience
17. The GP asks me if I am satisfied with the organisation of my care 0.497 0.408 Experience
18. The GP contacts me to know how things are going 0.520 −0.012 Experience
Factor 2
1. The GP asks about my ideas when we made a treatment plan 0.468 0.573 Customisation
3. The GP gives me a copy of my treatment plan 0.638 0.673 Cooperation
4. The GP gives me choices about treatment to think about 0.596 0.684 Cooperation
9. The GP asks me to talk about my goals in caring for my illness 0.551 0.654 Customisation
11. The GP helps me to list things that I can do to improve my health 0.605 0.633 Cooperation
12. The GP refers me to a dietician, health educator, or counsellor 0.384 0.719 Cooperation
13. The GP encourages me to go to a specific group to help me with my chronic illnesses 0.252 0.888 Cooperation
14. The GP encourages me to attend programs in the community that could help me 0.318 0.767 Cooperation















2 0.42 0.21 0.657
Gender 1 0.09 0.09 0.676
Self-reported health 1 2.43 2.43 0.028
Age (in class) 3 1.70 1.70 0.019
Model: N = 147; degrees of freedom used = 9; R2 = 12.2%; P-value = 0.031.
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Overall, the Cronbach alpha coefficient showed a somewhat
high level of internal consistency for the 18-items French-
PACIC questionnaire with a value close to 0.87. This meas-
ure was also used to test the internal consistency within
each dimension and the values were respectively 0.81
and 0.84. The ordinal alpha coefficient led to the same
conclusions about the reliability of the two dimensions
with values respectively of 0.89 and 0.88.
Implementation of the CCM in the French context
Overall the patients perceived the CCM as being moder-
ately well implemented in their chronic care (Table 3),
with a median PACIC score of 2. However this global as-
sessment hides differences between the two dimensions
of the questionnaire. The items pertaining to the 2nd di-
mension “Collaborative chronic care” appeared to be less
implemented than those of the 1st dimension “Personalised
chronic care”, with median scores respectively of 3 and 1.
However, the Wilcoxon test of signed rank suggested no
statistically significant difference between the PACIC scores
of these two dimensions (S = −342.5, P-value = 0.5096).
These results were consistent with the French context in
which the GP care is still mainly focused on acute condi-
tions and therefore most of the CCM recommendations
were not implemented. The French-version of the PACIC
can be obtained from the authors on request.
The ANOVA showed a significant effect of age and
the self-reported health (Table 6). The patients less than65 years old had a mean composite score higher than those
older than 65years, respectively 2.56 (SD=0.7) and 2.25
(SD=0.73). Interestingly, the patients who reported a some-
what good health state (i.e. good, very good, or excellent)
showed PACIC scores larger than those who reported a de-
teriorated health state (i.e. satisfactory or bad), respectively
2.6 (SD=0.73) and 2.3 (SD=0.7).
Discussion
This study has successfully translated and adapted the
PACIC questionnaire to the French context. The psycho-
metric properties of the French-version have been
tested and results have provided support of its validity.
The different analyses have left some issues that are
discussed below.
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instead of 5?
The initial English-version of the PACIC consisted in 5
dimensions derived from the components of the chronic
care model [17]. These dimensions were pre-specified
rather than identified through data analysis. In line with
this initial approach, most of the validation studies have
used the confirmatory factor analysis (CFA) method to
verify the adequacy of the data to this 5-dimensions
structure. Among the 7 studies identified in the litera-
ture, 4 provided support for a 5-dimensions structure
[24,27,37,38] and 3 suggested that such structure did
not adequately fit the PACIC data [28,39,40]. As in our
study, an alternative approach consisted in using an
exploratory factor analysis (EFA) to emerge the num-
ber of dimensions from the data. In the literature this
approach has been used in 5 studies, with 2 studies
identifying 5 dimensions [25,41] and the 3 others studies
identifying 1 or 2 dimensions [28,42]. Our 2-dimension
structure of the PACIC is more closely related to these last
validation studies which included items in more general
dimensions. At the extreme situation, Gugiu et al. discussed
the potential of PACIC data to emerge only one dimension
[28]. These differences of structure between the validation
studies may arise from methodological differences between
the studies. The studies validating the PACIC survey are
quite heterogeneous in the way they performed the factor
analysis (e.g. confirmatory vs exploratory analysis; Pearson
correlation vs Spearman or Polychorric correlation as input
matrix; Orthogonal vs Oblique rotation of the factors;
Kaiser criterion + Scree plot vs Parallel analysis to select
the factors). As in Gugiu et al. [28], this study relied on
non-standard, but theoretically more appropriate, meth-
odological choices (i.e. Oblique rotation; WLS estimator;
Parallel analysis; Exploratory/Confirmatory analysis) and
raises doubt about the structure of the PACIC in 5 dimen-
sions. These factorial differences might also arise from
true differences between the health systems and the sample
of patients in which the studies took place. Some studies
are especially interested on the perspective of patients
suffering from some chronic condition, whereas other
studies focused on patients suffering from multiple chronic
conditions, like our study.
Why a version of the questionnaire in 18 items instead of 20?
Merging 4 items into 2 was a direct consequence of the
active role played by respondents in the adaptation of
the PACIC questionnaire. They merged items perceived
as redundant. Second, the removal of two items with
very high level of “Never” responses suggested that these
items were not appropriate to describe the way chronic
conditions were managed in primary care in France. As
previously discussed by Rick et al. (2012), Wensing et al.
(2008) and Spicer et al. (2010), the PACIC questionnairehas been firstly developed in a specific context, namely
the United States, where the organization of the health-
care system and current initiatives in terms of chronic
disease management may differ from other countries
[18,39,41]. Then in terms of face validity it was deemed
necessary to adapt the PACIC questionnaire to each
context in which it was transposed to adequately reflect
the experience of the patients. Other studies have also
removed or reframed some initial PACIC items during
the adaptation/translation process. McIntosh (2008) sug-
gested a 17-items version [40] and Gugiu et al. have de-
veloped a valid short-form of the PACIC questionnaire
in 11 items [19].
What about the relationships of the PACIC scores with
individual characteristics?
In our study, we found significant relationships between
the overall PACIC score and two patients’ characteristics,
namely the age and the self-reported health. These results
are partly in line with the literature. In terms of self-
reported health, 2 studies have previously investigated the
relationship with the PACIC score(s) and concluded to
significance [37,42]. In terms of age, the evidence is mixed:
in the 9 studies which tested the relationship with PACIC
score, only 3 showed a significant result [38,39]. Regarding
the other characteristics tested in our study, the results
are also in line with the literature: 5 studies out of 7 found
no relationship between number of consultations and
PACIC score, and 7 studies out of 10 found no relation-
ship between the gender and PACIC score. Only one
study has previously analyzed the effect of the number
of chronic conditions and did not conclude there was a
significant difference [37], like us. In our study, we have
not investigated potential differences in PACIC scores
according to the type of chronic conditions. However,
Glasgow et al. have tested the initial English-version of
the PACIC in populations with various chronic condi-
tions and displayed no differences in its psychometric
properties across these conditions [17]. Developers of
the chronic care model argued that this model was
generic and could be successfully applied to variety of
chronic conditions [11,43].
What about the implementation of the chronic care model?
According to the overall PACIC score, our results appear
to be consistent with other studies performed in differ-
ent countries and chronic conditions. We identified 17
studies that reported an overall PACIC score which
ranged from 2.4 [39] to 3.2 [17] with a median of 2.84.
With an overall PACIC score of 2.6, our study is in line
with the studies of Vrjihoef et al. and Glasgow et al. re-
spectively performed on 89 and 266 patients suffering
from multiple chronic conditions in the Netherlands and
in USA [24,44]. The comparison of our result with those
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French and German healthcare systems shared com-
mon organizational features [45]. In addition Szecsenyi
et al. used the PACIC questionnaire in two populations
of diabetes patients, one who participated in a disease
management programme and the other not. They
showed a significant difference of overall PACIC score
between these two groups of patients (i.e. 3.21 vs 2.86).
A similar disease management programme is currently
implemented in France and we assume that similar
pattern of results should be identified using this
French-version of the PACIC questionnaire.
Limitations
It is important to note that our study has some limita-
tions. First, the primary objective of this study was to
validate the PACIC survey in the French language on a
sample of patients suffering from multiple chronic con-
ditions. For this purpose, we selected patients suffering
from the OSAS as a well-designed population for this
study because they are usually suffering from other chronic
conditions (e.g. diabetes, hypertension, arthritis) and
they experience complex medical care involving many
health professionals in different places. Despite this,
we used selective inclusion criteria to recruit only pa-
tients with a stabilized OSAS (i.e. asymptomatic condi-
tion and treatment well accepted by the patients), we
cannot preclude any potential influence on our results.
Instead of comparing results across different chronic
conditions, for future research on the PACIC, it would
be interesting to compare the ratings after controlling
for patients’ ease of interaction with the healthcare system
(i.e. number of consultation, self-perceived difficulty to
get the needed service) and self-perceived health con-
dition. Second, the sample size of recruited patients
can be considered as being on the lower bound of ac-
ceptability. Despite being in line with a part of the
international literature with a 5:1 subject to variable
ratio, conventional recommendations are closer to 10:1.
Moreover, these recommendations are based on continu-
ous data, which we do not have. The ratio for ordinal data
is higher. Thus our sample size might be too restrictive for
further analyses, for example, based on structural equation
modeling. However our results are still in accordance
with part of the PACIC literature using same analytical
approach, thus providing confidence in our results.
Third, retest reliability was not examined. To date only
three studies have investigated this issue and showed
mixed evidence according to intervals (i.e. 2 weeks, 3 or
8 months) used between the two measurement points
[17,19,25]. On a sample of 56 patients, Rosemann et al.
[25] showed a good reproducibility of PACIC scores using
a 2-weeks interval (r = 0.81). On a sample of 250 patients
and using a short-version of the PACIC survey, Gugiuet al. [19] showed a reasonable test-retest reliability at
8 months (r = 0.638).
Fourth, we have not tested the concurrent (or external)
validity of our adaptation, because we lack of patient sur-
veys developed and validated in French language. Wensing
et al. explored this issue using the EUROPEP instrument
and they showed strong correlations between PACIC and
EUROPEP scales [41].
Fifth, we have not tested the sensitivity to changes of the
PACIC ratings. Few studies have investigated this issue
and showed mixed evidence. Maindal et al. investigated
the sensitivity to change (i.e. enrollment in a disease man-
agement programme) of the PACIC among 585 patients
with chronic vascular diseases and showed that the PACIC
scores improved significantly [37].
Conclusion
In this study, we have successfully translated, culturally
adapted and validated a French-version of the PACIC
questionnaire. This tool may now be used in population
of patients with multiple chronic conditions to measure
the level of CCM achievement from their perspective,
and to monitor the quality improvements realized by
the medical structures, mainly in general practice.
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